184 SCLC patients’ primary tumour samples were analyzed for ERCCI, BRCA1, ATP7B, PKM2TOPOI, TOPOIIA, TOPOIIB and C-MYC mRNA expression. This evidence concerns the gene MYC and neoplasm.